MedTrace Logo

Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder

NCT00203385 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-04-26

No results posted yet for this study

Summary

The primary objective is to evaluate the long-term efficacy of divalproex sodium (Depakote) in the continuation treatment of PTSD.

Conditions

Interventions

DRUG

Divalproex

Depakote up to 2000mg/d

Sponsors & Collaborators

  • Tuscaloosa Research & Education Advancement Corporation

    lead OTHER

Principal Investigators

  • Lori L Davis, MD · Tuscaloosa Veterans Affairs Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Primary Completion
2005-03-31
Completion
2005-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00203385 on ClinicalTrials.gov